Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| SFACG.com | 2022 | Series B | Undisclosed | Guangzhou |
| QYSEA | 2022 | Series B | $1.6M | Shenzhen |
| Leyue Health | 2021 | Series B | Undisclosed | Beijing |
| KingstronBio | 2021 | Series C | $47.0M | Changshu |
| Jihai Technology | 2021 | Series A | Undisclosed | Shenzhen |
| Qlife Lab | 2021 | Private Equity | Undisclosed | Nanjing |
| New Core Technology (Xinyunhe) | 2021 | Series C | $35.0M | Shanghai |
| XinHeYun | 2021 | Series C | $30.9M | Nanyuan |
| Tendfo | 2021 | Series A | $15.4M | Shanghai |
| Hangzhou Stupa Network Technology | 2021 | Series B | $15.5M | Hangzhou |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | SFACG.com | Series B | Undisclosed | Guangzhou, China |
| 77 | QYSEA | Series B | $1.6M | Shenzhen, China |
| 78 | Leyue Health | Series B | Undisclosed | Beijing, China |
| 79 | KingstronBio | Series C | $47.0M | Changshu, China |
| 80 | Jihai Technology | Series A | Undisclosed | Shenzhen, China |
| 81 | Qlife Lab | Private Equity | Undisclosed | Nanjing, China |
| 82 | New Core Technology (Xinyunhe) | Series C | $35.0M | Shanghai, China |
| 83 | XinHeYun | Series C | $30.9M | Nanyuan, China |
| 84 | Tendfo | Series A | $15.4M | Shanghai, China |
| 85 | Hangzhou Stupa Network Technology | Series B | $15.5M | Hangzhou, China |
SFACG.com is an online media and entertainment company.
QYSEA is a technology company that provides research and development of underwater robot systems and remotely operated underwater vehicles.
Leyue Health provides commercial health insurance intelligent risk control and claims settlement services.
KingstronBio manufactures artificial heart valves and annuloplasty rings.
Jihai Technology is an e-commerce platform providing smart devices like smart home cleaning tools, auto accessories, and smart gadgets.
Qlife Lab is a biomedical company that provide health diagnosis services that uses clinical mass spectrometry for cardiovascular disease.
A Shanghai-based Internet company.
New Nuclear Cloud is a cloud ERP system development company.
Tendfo develops a medical device for pulmonary embolism interventional therapy.
Hangzhou Stupa Network Technology is committed to providing enterprises with a comprehensive range of performance solutions
InRoad is a digital software system that provide solutions to the chemical industry.
I personnel is an integrated human resource SaaS provider.
Zonsen Peplib Biotech is a peptide compound library and provides peptide drug discovery.
HappyCast is a multi-screen interactive technology solution provider.
Gmax Biopharm develops GPCR antibody therapeutics for unmet medical needs in cardiovascular diseases, metabolic disorders, and cancer.
Industics.com is an industrial Internet platform that provides industrial software, hardware, and lean management consulting services.
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.
The first business intelligence software for amazon sellers
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.
Quest Genomics is a company that provides tumour genetic testing instruments and reagents for research and development.
Baijia Food is an agricultural product processing demonstration enterprise.
Huixuan is the provider of consumer installment loan related services for financial institutions.
First Future is a B2B online foreign education service provider company.
Atrusty.com is a cross-border mattress supply chain service platform.
Yungehuo is a Logistics company.
Cowin Capital has invested in 142 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cowin Capital's top investment sectors include Biotechnology, Software, Health Care, Medical, Manufacturing. The firm invests across 49 different industry categories.
Among tracked funding rounds, Biotheus received $100.0M in a Series D round. Cowin Capital's total known invested capital is $1.2B.
Cowin Capital's average investment size is $16.3M across its portfolio of 142 companies.
Recent Cowin Capital portfolio additions include SFACG.com, QYSEA, Leyue Health, KingstronBio, Jihai Technology. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors